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Neuronal nicotinic acetyfcholine r ceptors (AChRs) from brains of chickens and rats consist of two types 
of subunits, tl and fi, of which a shares ome antigenic determinants with E-subunits from AChRs of electric 
organ and muscle [( 1986) Biochemistry 25,2082-2093; (1986) J. Neurosci. G, 3061-3069; (1986) Proc. Natl. 
Acad. Sci. USA, in press]. Here we demonstrate that after reduction with dithiothreitol (DTT) the AChRs 
can be specifically labelled with the acetylcholine-binding site directed reagent 4-(N-maleimido)benzyltri 
t3H]methyiammonium iodide. Labelling of the ~-subunit of neuronal nicotinic AChRs indicates that the 
acetylcholine-binding site, and amino acids which may be homologous to Cys 192-193 of the a-subunits 
of AChRs from electric organ and muscle, are located on the &subunit of neuronal AChRs. These results 
suggest hat although neuronal nicotinic AChRs have some structural homologies to AChRs from muscle 
and electric organs, the AChRs from these sources are quite distant relatives in an extended gene family. 
Acetylcholine receptor; Nicotine; Affinity labeling; Monoclonal antibody; (Brain) 
1. INTRODUCTION 
Avian and mammalian brains contain both 
nicotinic binding sites which have high affinity for 
nicotine and acetylcholine but not for (Y- 
bungarotoxin (cwBgt), and distinct cuBgt-binding 
sites [2-51. The function of the crBgt-binding sites 
remains obscure, since there have been umerous 
reports that NBgt fails to block neuronal AChR 
function [6-81. Neuronal nicotinic AChRs which 
do not bind aBgt have remained elusive until very 
recently, due to the lack of a suitable biochemical 
probe. We have used monoclonal antibodies 
(mAbs) to purify and characterize these neuronal 
AChRs. mAb 35, raised to AChRs from Elec- 
~~op~o~~s electric organ, crossreacted with an 
AChR from chicken brain [9]. This AChR bound 
nicotine with high affinity, but did not bind LvBgt 
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[ 1,2]. The immunoaffinity-purified brain AChR 
had two subunits, of M, 49000 (a) and 59000 0, 
the smaller of which bound antisera and mAbs to 
a-subunits from AChRs of electric organ and mus- 
cle [l]. Antisera raised to the chicken brain AChR 
specifically blocked the acetylcholine-induced 
depolarization of chick ciliary ganglion neurons in 
culture [lo], demonstrating that the component 
bound by mAb 35 was a functional AChR. mAbs 
raised to the chicken brain AChR identified a se- 
cond chicken brain AChR subtype which bound 
mAb 35 only weakly, and consisted of apparently 
the same a-subunit but a different &subunit, p’, 
of M, 75000 (submitted). mAb 270, raised to 
chicken brain AChRs, crossreacted with a 
homologous AChR from rat brain, and was used 
to immunoaffinity purify this receptor. The recep- 
tor from rat brain is homologous to the Afl’ sub- 
type from chicken brain and consists of two types 
of subunits, LY (Mr 51000) and,&’ (Mr 79ooO). mAb 
270 bound to the cu-subunits of AChRs from the 
brains of chickens and rats, as did antisera to cy- 
subunits of Torpedo AChR [3]. 
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The localization of the nemotransmitter-binding 
sites to the a-subunits of electric organ and muscle 
AChRs was determined using the affinity 
alkylating reagents bromoacetylcholine (BAC) 
and 4-(ZV-maleimido)benzyltri[3H]methylammoni- 
urn iodide (MBTA) [ 1 l-131. Reaction of these 
reagents depends upon the fact that there is a 
disulfide bond which is easily reduced directly ad- 
jacent to the acetylcholine-binding site. In 
Torpedo AChR, this disulfide bond is believed to 
be formed between Cys 192-193 of the a-subunit 
[ 141. We have previously demonstrated that reduc- 
tion followed by affinity alkylation of brain 
AChRs with BAC inhibits [3H]nicotine binding to 
these receptors [2], suggesting that residues 
homologous to Cys 192-193 are conserved in 
neuronal AChRs. Here, we show that MBTA 
similarly blocks [3H]nicotine binding and that 
[3H]MBTA specifically labels the P-subunit of 
AChRs from brains of chickens and rats. 
2. MATERIALS AND METHODS 
2.1. Antibodies 
mAb 35 was raised to AChRs from Elec- 
trophorus electric organ [ 151. mAbs 270 and 285 
were prepared from rats immunized with affinity- 
purified chicken brain AChR. Their production 
and characterization will be described elsewhere 
(Whiting et al., submitted). Preparation of an- 
tibody affinity columns has been described [ 1,3]. 
mAb 35 was coupled to CNBr-activated Sepharose 
CL4B at 6 mg protein/ml, mAb 270 at 6 mg pro- 
tein/ml, and mAb 285 at 9.6 mg protein/ml. 
2.2. Brain extracts 
Rat and chicken brains were obtained from Pel- 
Freeze Biologicals. Triton X-100 extracts of brains 
were prepared as in [ 1,3]. 
2.3. PHJNicotine-binding assay 
[3H]Nicotine (DL-[N-methyl-3H]nicotine; spec. 
act. 68.8 Ci/mmol, New England Nuclear) binding 
to AChR immobilized on mAbs was determined as 
described [2]. 
2.4. Labeiling of AChRs with pH]MBTA 
Detergent extracts of 70-90 chicken brains 
(250-350 ml, 0.2-0.3 nM [3H]nicotine-binding 
sites) or 30-40 rat brains (160-190 ml, 
56 
0.3-0.5 nM [3H]nicotine-binding sites) were recir- 
culated for 15 h at 4°C through 200~1 mAb 35 
Sepharose and mAb 285 Sepharose (chicken brain 
extract) or mAb 270 Sepharose (rat brain extract). 
mAb 35 Sepharose (200 ~1) was also gently shaken 
for 15 h at 4°C with 50 pmol affinity-purified 
Torpedo AChR, in 500 ~1 final volume 10 mM Na 
phosphate, pH 7.5, 100 mM NaCl (PBS) contain- 
ing 0.5% Triton X-100. The affinity gels were 
divided into two aliquots in 1.5 ml microfuge 
tubes, washed with 4 x 1 ml PBS, 0.5% Triton 
X-100 by pelletting and resuspension, and then 
reduced for 40 min with 200 ~1 of 1 mM DTT in 
the same buffer. A Torpedo AChR control tube 
was reduced in the presence of 1 pM cuBgt. The ali- 
quots were then rapidly washed with 1 ml PBS, 
0.5% Triton X-100 and then alkylated for 3 min 
with 1 x 10e5 M [3H]MBTA (spec. act. 
1900 cpm/pmol, a gift from Dr Mark McNamee) 
in the presence or absence of 1 pM aBgt (for 
Torpedo AChR) or 2 mM nicotine (for brain 
AChRs) in 200~1 final volume. The aliquots were 
rapidly washed with 4 x 1 ml PBS containing 
0.5% Triton X-100. Bound protein was then eluted 
from the antibody columns by 5 min incubations 
with 2 x 150 ~1 volumes of 50 mM sodium citrate, 
pH 3.0, 0.1% Triton X-100, and rapidly neutral- 
ized with 1 M Tris. The eluates were shaken for 2 h 
at 4°C with 50~1 goat anti-rat IgG coupled to 
Sepharose 4B (to absorb any IgG heavy and light 
chains which may have been onspecifically la- 
belled with the [3H]MBTA and subsequently leak- 
ed from the column during the elution procedure). 
The eluate was then lyophilized, resuspended in 
SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE) sample buffer and resolved by SDS 10% 
PAGE, as described [l]. The acrylamide gels were 
then impregnated with Enhance (New England 
Nuclear), dried, and fluorographed for 4-21 dys at 
-70°C using preflashed Kodak XAR film. 
3. RESULTS 
Affinity labelling of brain AChRs was in- 
vestigated by immuno-isolating the AChRs on 
mAbs coupled to Sepharose. mAb 35 was used to 
immobilize the chicken brain AChR subtype &, to 
which it preferentially binds; mAb 35 also binds to 
the a;a’ AChR subtype, but with lower affinity 
(submitted). mAb 285 was used to immobilize the 
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Fig.1. Affinity labelling with BAC (0) and MBTA (0) 
of chicken brain AChR immobilized upon (A) mAb 35, 
and (B) mAb 285, and (C) rat brain AChR immobilized 
upon mAb 270. Chicken brain detergent extracts (600 ~1) 
(A,B) or 200~1 rat brain detergent extract (C) were 
gently shaken in 1.5 ml microfuge tubes for 15 h at 4°C 
with 30 pl goat anti-rat IgG Sepharose and (A) 0.5 pl 
mAb 35 (anti-Torpedo AChR titer 49 pM cuBgt-binding 
sites), (B) 0.5 gl mAb 285 (anti-chicken brain AChR titer 
1.4pM nicotine-binding sites), or (C) 1.0 ~1 mAb 270 
(anti-chicken brain AChR titer 0.33 ,uM nicotine-binding 
sites). The aliquots were washed by brief pelletting and 
resuspension with 1 ml PBS, 0.5% Triton X-100, and 
then reduced for 40 min at room temperature with 
1 mM DTT in the same buffer. After washing with 1 ml 
PBS, 0.5% Triton (without DTT) the aliquots were 
resuspended in 100 pl of various concentrations of BAC 
(prepared by the method of Chiou and Sastry [26]), or 
MBTA [ll] in the same buffer. After 5 min at room 
temperature, the aliquots were washed with 4 x 1 ml 
chicken brain AChR c+3’ subtype. This mAb is 
directed to the ,8’-subunit, and thus specifically 
binds the &’ AChR subtype (submitted). mAb 
270, which is directed to the cr-subunit [2,3], was 
used to immobilize AChRs from rat brain. 
Fig.1 shows the affinity alkylation of AChRs 
from brains of chickens and rats by both BAC and 
MBTA, as measured in terms of inhibition of 
[3H]nicotine binding to immuno-isolated AChRs. 
This confirms our previous data showing affinity 
labelling with BAC of chicken brain AChRs im- 
mobilized upon mAb 35 Sepharose [1,2]. For both 
receptor subtypes from chicken brain (fig.lA,B) 
and receptor from rat brain (fig.lC), the affinity 
labels were able to inhibit greater than 90% of the 
[3H]nicotine binding. Higher concentrations of 
MBTA than BAC were required to affinity label 
the brain AChRs. Since MBTA is an antagonist 
and BAC an agonist, this observation is consistent 
with the demonstration that these receptors have 
high-affinity binding for nicotinic cholinergic 
agonists and considerably lower affinity binding 
for nicotinic cholinergic antagonists [2]. In con- 
trast, higher concentrations of BAC than MBTA 
are required to affinity label the ganglionic type 
neuronal AChRs of PC12 cells [ 161, which is con- 
sistent with their considerably lower affinity for 
nicotinic agonists compared to AChRs from brain 
u71. 
PBS, 0.5% Triton X-100 to remove noncovalently 
bound affinity ligand and then incubated for 10 min in 
0.1 mM dithiobis(2-nitrobenzoic acid). After washing 
with 2 x 1 ml PBS, 0.5% Triton, the aliquots were 
incubated for 15 min at room temperature, in 50~1 
[‘HInicotine (20 nM) in PBS, 0.5% Triton X-100. The 
aliquots were rapidly washed at 4°C with 3 x 1 ml ice- 
cold PBS, 0.5% Triton X-100. Bound protein and 
[3H]nicotine were eluted by brief incubation with 100 pl 
of 2.5% SDS, 5% mercaptoethanol and radioactivity 
determined by taking the eluate for scintillation counting 
[2]. A parallel incubation, in which the affinity 
alkylation step was omitted, was carried out, and the 
[3H]nicotine binding considered as 100% and all other 
values expressed relative to this. Each point is the mean 
of triplicate aliquots. Nonspecific binding of [3H]nico- 
tine was determined by incubation in the absence of 
mAb. In all experiments it represented less than 5% of 
the total binding, and has been subtracted from all 
values. 
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Fig.2. Fluorogram of SDS-PAGE of AChRs from 
Torpedo electric organ, chicken brain, and rat brain 
labelled with [3H]MBTA. Labelling procedures and 
SDS-PAGE were carried out as described in section 2. 
Apparent A4, values were determined by resolving M, 
standards (BioRad) on the same gel and staining for 
protein with Coomassie blue. 
The AChR subunit labelled by the affinity 
ligand was determined by immobilizing AChR on 
mAb Sepharose, alkylating with [3H]MBTA in the 
presence or absence of excess cholinergic ligand, 
eluting the labelled protein, and subsequently 
analyzing by SDS-PAGE and fluorography. The 
feasibility of this approach was shown by 
demonstrating that Torpedo AChR, immobilized 
on mAb 35 Sepharose, could be specifically la- 
belled upon its a-subunit (fig.2). When AChR 
from chicken brain was immobilized on mAb 35 
Sepharose and affinity labelled with [3H]MBTA, 
two polypeptides were labelled, M, 60600 + 1700 
and M, 75600 f 400 (mean f SD, three labelling 
experiments), which correspond to the P-subunit 
(Mr 59000 [l]) and @‘-subunit (Mr 75 000, sub- 
mitted) of the chicken brain AChR subtypes 
(fig.2). The labelling was specific, since it was in- 
58 
hibited by 2 mM nicotine (fig.2). The &subunit 
was always more intensely labelled than the 
fl’-subunit, consistent with the higher affinity of 
mAb 35 for the c@ AChR subtype than the a/?’ 
subtype. When mAb 285 Sepharose was used to 
immobilize specifically the chicken brain AChR 
Cup’ subtype, a single polypeptide was labelled, M, 
75400 + 400 (mean + SD, two labelling experi- 
ments), corresponding to the p’-subunit of the 
AChR &’ subtype (fig.2). Similarly, rat brain 
AChR, immobilized on mAb 270 Sepharose, was 
specifically labelled with [3H]MBTA on a single 
polypeptide, M, 79600 + 500 (mean + SD, three 
labelling experiments) corresponding to the fl’- 
subunit of the rat brain AChR (Mr 79000, [3]). For 
both chicken brain AChR subtypes and the rat 
brain AChR, the [3H]MBTA labelling could also 
be blocked by 1 mM carbachol (not shown), con- 
firming that the [3H]MBTA was specifically la- 
belling the neurotransmitter-binding site of the 
neuronal AChRs. 
4. DISCUSSION 
The affinity labelling of AChRs after reduction 
with DTT suggests that amino acid residues which 
may be homologous to Cys cr192- 193 are con- 
served in AChRs from brain. The aBgt-binding 
proteins from brains of chicks [18] and rats [19] 
can also be affinity labelled with BAC and MBTA. 
Similarly, it has been shown that the functional 
AChRs on both rat PC12 cells [16] and chick 
ciliary ganglion neurons [lo] can be affinity la- 
belled. These ganglionic-type AChRs share some 
antigenic determinants with AChRs from brain 
[ 10,201 but are pharmacologically distinct, having 
several orders of magnitude lower affinities for 
cholinergic agonists [17,21]. Thus, amino acid 
residues homologous to Cys al92-193 of electric 
organ and muscle AChRs may have been con- 
served in the members of what appears to be an ex- 
tended gene family consisting of muscle and 
electric organ AChRs, brain AChRs, ganglionic 
AChRs, and brain cuBgt-binding proteins. 
The observation that the &subunits of the 
AChRs from chicken and rat brains were labelled 
by [3H]MBTA was surprising because we have 
previously observed that it was the smaller cy- 
subunit of these receptors which shared antigenic 
determinants with a-subunits from AChRs of elec- 
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tric organ and muscle, and thus was considered to 
be the a-subunit homologue [1,3]. In particular, 
the main immunogenic region was conserved on 
the a-subunit of AChRs from chicken brain [l], 
although not on AChRs from rat brain [2,3]. The 
main immunogenic region is a domain on the ex- 
tracellular surface of a-subunits of AChRs from 
electric organ and skeletal muscle against which 
the majority of antibodies are directed in an im- 
mune response to native AChRs [22]. Using mAbs, 
it has been localized on a-subunit from Torpedo to 
somewhere between amino acid residues 46 and 
127 [23]. The four kinds of subunits of AChRs 
from electric organs and muscle are thought to 
have evolved from a single primordial subunit by 
repeated gene duplication [24,25]. The subunits of 
neuronal nicotinic AChRs and aBgt-binding com- 
ponents probably also evolved from this primor- 
dial receptor along different lineages of this 
extended gene family. If it is assumed that the 
primordial subunit had homologues of both the 
main immunogenic region and (~192- 193, it ap- 
pears that in the course of gene duplication and 
subsequent evolution both of these features con- 
tinued to be expressed in a-subunits of AChRs 
from muscle, while in the case of neuronal AChRs 
the antigenic phenotype persisted in a-subunits 
while the Cys ~192-193 analogues persisted in P- 
subunits. 
The two chicken brain AChR subtypes, & and 
&3’, have virtually identical affinity for L-nicotine 
and similar or identical a-subunits, but are 
distinguishable by their&subunits, which have dif- 
ferent apparent molecular masses and bind dif- 
ferent mAbs (submitted). Thus, localizing the 
cholinergic binding site to the P-subunits of these 
AChRs was unexpected. The domain containing 
the neurotransmitter-binding site must be highly 
conserved on both of these &subunits. 
It is clear that although certain key structures, 
such as homologues of Cys @192-193, are con- 
served in some subunits of all AChRs, the AChRs 
from neurons have diverged considerably from 
those in electric organ and skeletal muscle. The ap- 
plication of molecular genetic techniques will allow 
determination of the amino acid sequences of the 
neuronal AChR subunits and will eventually lead 
to a better understanding of the structure and 
evolution of these neuronal AChRs and their func- 
tion in neurotransmission. 
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